SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000904454-23-000406
Filing Date
2023-06-22
Accepted
2023-06-22 17:19:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A s13da_062223-zurabio.htm SC 13D/A 77841
  Complete submission text file 0000904454-23-000406.txt   79498
Mailing Address 142 WEST 57TH STREET 11TH FLOOR, SUITE 09-126 NEW YORK NY 10019
Business Address 142 WEST 57TH STREET 11TH FLOOR, SUITE 09-126 NEW YORK NY 10019 646-813-2470
Athanor Capital, LP (Filed by) CIK: 0001730574 (see all company filings)

IRS No.: 320520630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Subject) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92696 | Film No.: 231034214
SIC: 2836 Biological Products, (No Diagnostic Substances)